CMPS

COMPASS Pathways plc [CMPS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

CMPS Stock Summary

Top 10 Correlated Stocks

CMPS

In the News

CMPS Financial details

Company Rating
-
Market Cap
568.97M
Income
-118.75M
Revenue
3.68M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
186
Optionable
No
Shortable
Yes
Earnings
06 May 2024
P/E
-4.16
Forward P/E
-
PEG
-3.91
P/S
-
P/B
1.92
P/C
-
P/FCF
-5.27
Quick Ratio
17.79
Current Ratio
18.55
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-2.39
EPS next Y
-
EPS next Q
-
EPS this Y
7.87%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-20.9%
-
-
-
-
SMA20
10.68%
SMA50
2.86%
SMA100
4.59%
Inst Own
-
Inst Trans
-
ROA
-39%
ROE
-61%
ROC
-0.46%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.01-12.75
52W High
-46.75%
52W Low
+27.8%
RSI
42.91
Rel Volume
2.64
Avg Volume
725.15K
Volume
1.91M
Perf Week
-9.36%
Perf Month
-5.89%
Perf Quarter
30.41%
Perf Half Y
26.53%
-
-
-
-
Beta
2.485
-
-
Volatility
0.31%, 0.71%
Prev Close
-3.62%
Price
6.39
Change
-9.49%

Something similar

Top by Market Cap
FB2A.DE
AVGO
V
META
VFINX
Same Sector
INVO
0R55.L
GLPG.AS
VIVE
ADXN
Top Correlated Stocks
EASEMYTRIP.NS
NAUT
MAUSY
CMS-PB
FCNCO
Similar Market Cap
1005.HK
CBH.TO
PACB
KJELL.ST
CPAAU

Company Profile

Healthcare Medical - Care Facilities
  • Volume Average 725.15K
  • Market Capitalization 568.97M
  • Employee 186
  • CEO Mr. Kabir Nath M.A., M.B.A.
  • Headquarters London,GB
  • IPO Date 2020-09-18
  • Website https://compasspathways.com

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.